Predictive factors for HbA1c and weight loss associated with semaglutide treatment in type 2 diabetes mellitus: real-world clinical evidence

ObjectiveThis study aimed to identify clinical predictors associated with reductions in HbA1c and weight among patients with type 2 diabetes mellitus (T2DM) treated with semaglutide in real-world clinical settings in Bulgaria.MethodsA retrospective analysis was conducted on 168 T2DM patients receivi...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Petya Milushewa, Yoanna Mitreva, Nevena Chakarova, Tsvetalina Tankova, Emilia Naseva, Valentina Petkova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-09-01
Subjects:	semaglutide type 2 diabetes obesity glycemic control weight loss real-world data
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1621892/full